从“脾虚瘀毒”理论治疗慢性萎缩性胃炎经验
Experiences in Treating Chronic Atrophic Gastritis from the Perspective of the “Spleen Deficiency, Blood Stasis, and Toxin” Theory
摘要: 慢性萎缩性胃炎(Chronic Atrophic Gastritis, CAG)作为一种胃癌前病变,其有效干预对降低胃癌风险至关重要。刘华一教授基于“脾虚瘀毒”理论,系统阐述了CAG的病机与治则。该理论认为,CAG的核心病机为本虚标实:“脾虚”为本,即中焦虚弱、运化失权,为疾病之始动与基础;“瘀、毒”为标,乃因虚致瘀,久病入络,湿热痰瘀搏结,化生毒邪,损及胃络,此为病情进展与癌变之关键。三者互为因果,形成恶性循环。在治疗上,主张以“扶正祛邪”为纲,立健脾益气之法以固其本,施活血化瘀、解毒散结之方以治其标。临床通过辨证论治,运用相应方药干预,可显著改善患者症状,促进胃黏膜修复与病理逆转(包括萎缩、肠化生及异型增生),从而延缓疾病进程。结论:以刘华一教授“脾虚瘀毒”理论为指导的健脾化瘀解毒法,是治疗CAG的有效策略,深刻体现了中医“治病求本”与“既病防变”的思想,临床价值显著,应用前景广阔。
Abstract: Chronic Atrophic Gastritis (CAG), as a precancerous gastric lesion, requires effective intervention to mitigate the risk of gastric cancer. Professor Liu Huayi, based on the “Spleen Deficiency, Blood Stasis, and Toxin” theory, has systematically elucidated the pathogenesis and treatment principles of CAG. This theory posits that the core pathogenesis of CAG is a deficiency-root with excess-manifestations: “Spleen Deficiency” constitutes the root, referring to weakness of the middle energizer and impaired transportation and transformation, which is the initiating factor and foundation of the disease. “Blood Stasis and Toxin” are the manifestations, arising when deficiency leads to stasis, chronic disease penetrates the collaterals, and dampness, heat, phlegm, and stasis intermingle to generate pathogenic toxins that damage the stomach network. This process is critical for disease progression and carcinogenesis. These three elements interact reciprocally, forming a vicious cycle. Regarding treatment, the principle of “Supporting Healthy Qi and Eliminating Pathogenic Factors” is advocated, establishing the method of Fortifying the Spleen and Boosting Qi to secure the root, while applying strategies of Activating Blood Circulation to Resolve Stasis, and Detoxifying to Dissipate Nodules to address the manifestations. Clinical practice guided by syndrome differentiation and treatment, utilizing corresponding herbal formulations, can significantly alleviate patient symptoms, promote gastric mucosal repair and pathological reversal (including atrophy, intestinal metaplasia, and dysplasia), thereby slowing disease progression. In conclusion, the therapeutic method of fortifying the spleen, resolving stasis, and detoxifying, guided by Professor Liu Huayi’s “Spleen Deficiency, Blood Stasis, and Toxin” theory, represents an effective strategy for treating CAG. It profoundly embodies the TCM concepts of “treating disease by seeking the root” and “preventing disease progression”, demonstrating significant clinical value and broad application prospects.
文章引用:郑晨露, 孙家宝, 刘华一. 从“脾虚瘀毒”理论治疗慢性萎缩性胃炎经验[J]. 中医学, 2025, 14(11): 5175-5180. https://doi.org/10.12677/tcm.2025.1411744

参考文献

[1] Rodriguez-Castro, K.I., Franceschi, M., Noto, A., Miraglia, C., Nouvenne, A., Leandro, G., Meschi, T., De’Angelis. G.L. and Di Mario, F. (2018) Clinical Manifestations of Chronic Atrophic Gastritis. Acta Biomedica, 89, 88-92.
[2] Conti, C.B., Agnesi, S., Scaravaglio, M., Masseria, P., Dinelli, M.E., Oldani, M., et al. (2023) Early Gastric Cancer: Update on Prevention, Diagnosis and Treatment. International Journal of Environmental Research and Public Health, 20, Article No. 2149. [Google Scholar] [CrossRef] [PubMed]
[3] 中华中医药学会脾胃病分会, 中华医学会消化病学分会消化肿瘤协作组, 中华医学会消化内镜学分会早癌协作组, 等. 中国整合胃癌前病变临床管理指南[J]. 中国中西医结合消化杂志, 2022, 30(3): 163-183.
[4] Kuang, W., Xu, J., Xu, F., Huang, W., Majid, M., Shi, H., et al. (2024) Current Study of Pathogenetic Mechanisms and Therapeutics of Chronic Atrophic Gastritis: A Comprehensive Review. Frontiers in Cell and Developmental Biology, 12, Article ID: 1513426. [Google Scholar] [CrossRef] [PubMed]
[5] Jia, J., Zhao, H., Li, F., Zheng, Q., Wang, G., Li, D., et al. (2024) Research on Drug Treatment and the Novel Signaling Pathway of Chronic Atrophic Gastritis. Biomedicine & Pharmacotherapy, 176, Article ID: 116912. [Google Scholar] [CrossRef] [PubMed]
[6] 纪云飞, 王瑞君, 李晓波. 复方四君子汤的化学成分和药理作用研究进展[J]. 中草药, 2016, 47(5): 837-843.
[7] 杜芳. 四君子汤加减治疗对慢性萎缩性胃炎患者的疗效与安全性分析[C]//中国生命关怀协会. 关爱生命大讲堂之生命关怀与智慧康养系列学术研讨会论文集(中)——银发浪潮下老年护理的挑战与机遇专题. 廊坊: 霸州市中医院, 2025: 589-591.
[8] 孔令雷, 杜冠华. 丹参饮的现代研究进展[J]. 中药药理与临床, 2019, 35(3): 197-200.
[9] 黄雪, 李跃文, 董小飞, 等. 四君子汤合丹参饮加减对慢性萎缩性胃炎的疗效及对患者血液流变学与肾素-血管紧张素系统的影响[J]. 浙江中西医结合杂志, 2025, 35(7): 624-628.
[10] 姚自凤, 崔杰, 杨建洲. 浅析四君子汤的方义及其临床应用[J]. 中医研究, 2015, 28(6): 72-74.
[11] 魏巍, 王冰瑶. 莪术及其主要成分的药理作用研究进展[J]. 药物评价研究, 2022, 45(10): 2154-2160.
[12] 刘耀晨, 张铁军, 郭海彪, 等. 三七的研究进展及其质量标志物预测分析[J]. 中草药, 2021, 52(9): 2733-2745.
[13] 陈诗, 赵玥, 王振, 等. 山慈菇药理作用及临床应用研究进展[J]. 中华中医药学刊, 2023, 41(6): 247-250.
[14] 张宇飞, 李力恒, 陈昌瑾, 等. 白花蛇舌草抗肿瘤的药理机制及药代动力学研究进展[J]. 中医药学报, 2025, 53(1): 111-117.
[15] 梁春晓, 王珊珊, 陈淑静, 等. 虎杖化学成分及药理活性研究进展[J]. 中草药, 2022, 53(4): 1264-1276.